Upgrade to SI Premium - Free Trial

UPDATE: UBS Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Sell

November 11, 2022 5:27 AM
(Updated - November 11, 2022 7:55 AM EST)

UBS analyst Michael Leuchten downgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades Hot Downgrades Intl Ratings

Next Articles